XF-7SS8DZ4-U
Second Party Opinion ACTIVE

ISS ESG Second Party Opinion — Royalty Pharma plc

Document Metadata

Issuer
Royalty Pharma plc
Document Type
Second Party Opinion
Publication Year
2021
Retrieved
20 March 2026
Source
Contact XFID for Access
Record ID
XF7SS8DZ4U
Validation
Inferred by XFID

Assessment Provider

People Cited in This Document

How to Cite This Record

Use the XFID in citations to create a stable, permanent reference that resolves to this registry entry regardless of the source URL.

Academic / report citation
Royalty Pharma plc (2021). ISS ESG Second Party Opinion — Royalty Pharma plc. XFID: XF-7SS8DZ4-U. Retrieved from https://xframework.id/XF7SS8DZ4U
Identifier only
XF-7SS8DZ4-U